282 related articles for article (PubMed ID: 34414762)
1. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy.
Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J
ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
[TBL] [Abstract][Full Text] [Related]
4. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
[TBL] [Abstract][Full Text] [Related]
5. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G
J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
8. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
Ramesh A; Malik V; Brouillard A; Kulkarni A
J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
[TBL] [Abstract][Full Text] [Related]
9. Functional 2D Iron-Based Nanosheets for Synergistic Immunotherapy, Phototherapy, and Chemotherapy of Tumor.
Wang X; Cheng Y; Han X; Yan J; Wu Y; Song P; Wang Y; Li X; Zhang H
Adv Healthc Mater; 2022 Oct; 11(19):e2200776. PubMed ID: 35912918
[TBL] [Abstract][Full Text] [Related]
10. Repolarizing tumor-associated macrophages by layered double hydroxide-based deacidification agent for tumor chemodynamic therapy and immunotherapy.
Chen C; Zhang W; Lu SY; Wang J; Tan Y; Zhao S; Ouyang Y; Xu L; Zhou B; Yin X; Ran H; Liu H
Colloids Surf B Biointerfaces; 2023 Mar; 223():113157. PubMed ID: 36716658
[TBL] [Abstract][Full Text] [Related]
11. A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief.
Jiang M; Qin B; Luo L; Li X; Shi Y; Zhang J; Luo Z; Zhu C; Guan G; Du Y; You J
J Control Release; 2021 Jul; 335():408-419. PubMed ID: 34089792
[TBL] [Abstract][Full Text] [Related]
12. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
13. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
14. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
15. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects.
Xiao H; Guo Y; Li B; Li X; Wang Y; Han S; Cheng D; Shuai X
ACS Cent Sci; 2020 Jul; 6(7):1208-1222. PubMed ID: 32724855
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy.
Kang Y; Lim J; Saravanakumar G; Kim J; Park M; Im S; Kim WJ
J Control Release; 2022 Mar; 343():78-88. PubMed ID: 35065158
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
Qiao X; Hu Z; Xiong F; Yang Y; Peng C; Wang D; Li X
Lipids Health Dis; 2023 Mar; 22(1):45. PubMed ID: 37004014
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming Hypoxic Tumor-Associated Macrophages by Nanoglycoclusters for Boosted Cancer Immunotherapy.
Zhao YD; An HW; Mamuti M; Zeng XZ; Zheng R; Yang J; Zhou W; Liang Y; Qin G; Hou DY; Liu X; Wang H; Zhao Y; Fang X
Adv Mater; 2023 Jun; 35(24):e2211332. PubMed ID: 36971342
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced m2-polarization of macrophages.
Dubey P; Shrivastava R; Tripathi C; Jain NK; Tewari BN; Lone MU; Baghel KS; Kumar V; Misra S; Bhadauria S; Bhatt ML
Cell Mol Biol (Noisy-le-grand); 2014 Sep; 60(3):10-5. PubMed ID: 25210855
[TBL] [Abstract][Full Text] [Related]
20. ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy.
Mo W; Liu S; Zhao X; Wei F; Li Y; Sheng X; Cao W; Ding M; Zhang W; Chen X; Meng L; Yao S; Diao W; Wei H; Guo H
Adv Healthc Mater; 2023 Aug; 12(21):e2300191. PubMed ID: 37031357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
